Trajan Group Holdings Limited (ASX: TRJ)

Market Cap	183.47M
Revenue (ttm)	155.02M
Net Income (ttm)	-25.33M
Shares Out	152.26M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	58.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,388
Open	1.200
Previous Close	1.200
Day's Range	1.200 - 1.210
52-Week Range	0.675 - 1.345
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Trajan Group Holdings

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, rings, inlet liners, and tubing products; pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, micro...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 600
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRJ